✦ LIBER ✦

SOLUBLE INTERLEUKIN-2 RECEPTORS IN SERUM AND BILE OF LIVER TRANSPLANT RECIPIENTS

✍ Scribed by Adams, D.H.; Hubscher, S.G.; Wang, L.; Elias, E.; Neuberger, J.M.

Book ID: 123122564
Publisher: The Lancet
Year: 1989
Tongue: English
Weight: 383 KB
Volume: 333
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(89)91368-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic (serum) soluble interleukin-2 r

Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients

✍ C. Stephen Foster; Helen K. Wu; Amyna Merchant 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 423 KB

Elevation of soluble interleukin-2 recep

Elevation of soluble interleukin-2 receptors during rejection in cardiac transplant recipients

✍ Howard J. Eisen; Sheri Belland; Ralph Nader; Rebekah Mull; William Kussmaul 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Soluble interleukin 2 receptor (sIL-2R)

Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients

✍ Rajil Mehta; Gaurang Shah; William Adler; Dilip Kittur 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Serum interleukin-2 receptor (IL-2R) lev

Serum interleukin-2 receptor (IL-2R) levels in recipients of liver allografts

📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Pros and cons of using interleukin-2 rec

Pros and cons of using interleukin-2 receptor antibodies in liver transplant recipients

✍ Ryutaro Hirose 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Serum-soluble interleukin-2 receptors in

Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies

✍ Pavlidis, Nicholas A. ;Manoussakis, Menelaus N. ;Germanidis, George S. ;Moutsopo 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

## Abstract The levels of soluble interleukin‐2 receptors (sIL‐2R) were determined in the serum of 53 patients with B‐cell lymphoproliferative malignancies, including 31 patients with non‐Hodgkin lymphomas (NHL), 16 with chronic lymphocytic leukemia (CLL), and 6 with multiple myeloma. In addition,